Impairment of Filgrastim-Induced Stem Cell Mobilization after Prior Lenalidomide in Patients with Multiple Myeloma

Lenalidomide is an agent that has shown great activity in patients with multiple myeloma. However, studies have suggested that this drug negatively affects subsequent stem cell collection. To investigate whether lenalidomide impairs stem cell mobilization and collection, we reviewed data for patient...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Biol Blood Marrow Transplant
Main Authors: Popat, Uday, Saliba, Rima, Thandi, Rupinderjit, Hosing, Chitra, Qazilbash, Muzaffar, Anderlini, Paolo, Shpall, Elizabeth, McMannis, John, Körbling, Martin, Alousi, Amin, Andersson, Borje, Nieto, Yago, Kebriaei, Partow, Khouri, Issa, de Lima, Marcos, Weber, Donna, Thomas, Sheeba, Wang, Michael, Jones, Roy, Champlin, Richard, Giralt, Sergio
Format: Artigo
Jezik:Inglês
Izdano: 2009
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352933/
https://ncbi.nlm.nih.gov/pubmed/19450756
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2009.02.011
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki